Hidemitsu Kitamura

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Regulatory T Cells

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

The Journal of experimental medicine

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

This page only lists publications with an associated author ORCID identifier.

Publications

Xin Sun, Toshiyuki Watanabe, Yoshitaka Oda, Weidong Shen, Alaa Ahmad, Ryota Ouda, Paul de Figueiredo, Hidemitsu Kitamura, Shinya Tanaka, Koichi S Kobayashi
Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I. Proceedings of the National Academy of Sciences of the United States of America 121 (6) (2024)
Xin Sun, Toshiyuki Watanabe, Yoshitaka Oda, Weidong Shen, Alaa Ahmad, Ryota Ouda, Paul de Figueiredo, Hidemitsu Kitamura, Shinya Tanaka, Koichi S Kobayashi
Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I. Proceedings of the National Academy of Sciences of the United States of America 121 (6) (2024)
Xin Sun, Toshiyuki Watanabe, Yoshitaka Oda, Weidong Shen, Alaa Ahmad, Ryota Ouda, Paul de Figueiredo, Hidemitsu Kitamura, Shinya Tanaka, Koichi S Kobayashi
Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I. Proceedings of the National Academy of Sciences of the United States of America 121 (6) (2024)
Xin Sun, Toshiyuki Watanabe, Yoshitaka Oda, Weidong Shen, Alaa Ahmad, Ryota Ouda, Paul de Figueiredo, Hidemitsu Kitamura, Shinya Tanaka, Koichi S Kobayashi
Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I. Proceedings of the National Academy of Sciences of the United States of America 121 (6) (2024)
Xin Sun, Toshiyuki Watanabe, Yoshitaka Oda, Weidong Shen, Alaa Ahmad, Ryota Ouda, Paul de Figueiredo, Hidemitsu Kitamura, Shinya Tanaka, Koichi S Kobayashi
Targeted demethylation and activation of NLRC5 augment cancer immunogenicity through MHC class I. Proceedings of the National Academy of Sciences of the United States of America 121 (6) (2024)
Weidong Shen, Xiangdong Wang, Huihui Xiang, Shunsuke Shichi, Hiroki Nakamoto, Saori Kimura, Ko Sugiyama, Akinobu Taketomi, Hidemitsu Kitamura
IFN-γ-STAT1-mediated NK2R expression is involved in the induction of antitumor effector CD8 + T cells in vivo. Cancer science (2023)
Weidong Shen, Xiangdong Wang, Huihui Xiang, Shunsuke Shichi, Hiroki Nakamoto, Saori Kimura, Ko Sugiyama, Akinobu Taketomi, Hidemitsu Kitamura
IFN-γ-STAT1-mediated NK2R expression is involved in the induction of antitumor effector CD8 + T cells in vivo. Cancer science (2023)
Shuhei Kii, Hidemitsu Kitamura, Shinichi Hashimoto, Kazuho Ikeo, Nobuki Ichikawa, Tadashi Yoshida, Shigenori Homma, Mishie Tanino, Akinobu Taketomi
STAT1-mediated induction of Ly6c-expressing macrophages are involved in the pathogenesis of an acute colitis model. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 71 (9) (2022)
Huihui Xiang, Yujiro Toyoshima, Weidong Shen, Xiangdong Wang, Naoki Okada, Shuhei Kii, Ko Sugiyama, Toshihiro Nagato, Hiroya Kobayashi, Kazuho Ikeo, Shinichi Hashimoto, Mishie Tanino, Akinobu Taketomi, Hidemitsu Kitamura
IFN-α/β-mediated NK2R expression is related to the malignancy of colon cancer cells. Cancer science 113 (8) (2022)
Akemi Kosaka, Kei Ishibashi, Toshihiro Nagato, Hidemitsu Kitamura, Yukio Fujiwara, Syunsuke Yasuda, Marino Nagata, Shohei Harabuchi, Ryusuke Hayashi, Yuki Yajima, Kenzo Ohara, Takumi Kumai, Naoko Aoki, Yoshihiro Komohara, Kensuke Oikawa, Yasuaki Harabuchi, Masahiro Kitada, Hiroya Kobayashi, Takayuki Ohkuri
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes. The Journal of experimental medicine 218 (11) (2021)
Yosuke Ohno, Yujiro Toyoshima, Hideaki Yurino, Norikazu Monma, Huihui Xiang, Kentaro Sumida, Shun Kaneumi, Satoshi Terada, Shinichi Hashimoto, Kazuho Ikeo, Shigenori Homma, Hideki Kawamura, Norihiko Takahashi, Akinobu Taketomi, Hidemitsu Kitamura
Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy. Cancer science 108 (10) (2017)
Hidemitsu Kitamura, Yosuke Ohno, Yujiro Toyoshima, Junya Ohtake, Shigenori Homma, Hideki Kawamura, Norihiko Takahashi, Akinobu Taketomi
Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy. Cancer science 108 (10) (2017)